Charles Schwab Investment Management »

Aligos Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $31k 31k 0.98
2023-12-31 $21k 31k 0.66
2023-09-30 $23k 31k 0.75
2023-06-30 $31k 31k 0.97
2022-06-30 $90k 74k 1.22
2022-03-31 $267k 124k 2.16
2021-12-31 $1.7M 139k 11.87
2021-09-30 $2.1M 135k 15.51
2021-06-30 $1.8M 89k 20.40
2021-03-31 $1.6M 72k 22.75
2020-12-31 $1.8M 65k 27.65